08.05.2014 Views

Introduction - Uppsala Monitoring Centre

Introduction - Uppsala Monitoring Centre

Introduction - Uppsala Monitoring Centre

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Delay in recognition: None<br />

Delay in regulatory action: 29 years<br />

Time span of withdrawals: 12 years<br />

Comment: the problem was finding whether there were sulphonamides that<br />

were better than sulfathiazole and it is probable that that caused the delay in<br />

withdrawal. Aplastic anaemia, agranulocytosis and thrombocytopenias are<br />

sulphonamide class effects (Albahary, 1953).<br />

1944 Di-hydro-streptomycin sulphate<br />

Use: an antibiotic.<br />

ADR: neuropsychiatric problems and ototoxicity. ‘Di-hydro-streptomycin is more<br />

toxic than streptomycin.’ (Minkenhet, 1950). Clinically the toxicity of di-hydrostreptomycin<br />

is much more significant, since it may easily cause partial or<br />

complete loss of hearing, whereas streptomycin tends to affect only the<br />

vestibular apparatus (Ruef & Blaser, 2000).<br />

SED 1952: some investigators are of the opinion that the toxicity for the<br />

vestibular and cochlear nerves is greater after prolonged use of<br />

dihydrostreptomycin than is the case with streptomycin (no reference was<br />

given).<br />

Withdrawn: in the USA in 1970, Philippines in 1972, Spain in 1983 and also in<br />

Dominica and Italy. HAI: banned in 6 countries.<br />

Availability: in Belgium, Poland, Mexico, Portugal, Philippines, Australia, Greece<br />

and Ireland (Martindale).<br />

Drug Lifespan: 26 years<br />

Delay in recognition: ≤ 8 years<br />

Delay in regulatory action: ≥ 18 years<br />

Time span of withdrawals: 13 years<br />

Comment: I haven’t found a paper which reports on a comparison between the<br />

two streptomycins. It was his deafness caused by di-hydro-streptomycin that<br />

prompted Leopold Meyler to write his famous textbook ‘The Side Effects of<br />

Drugs’.<br />

1947 Methapyrilene (Rinofol, Thenylene, Histadyl, Nytol)<br />

Use: a type 1 antihistamine<br />

ADR: produced hepatocellular carcinomas and cholangiocarcinomas in rats<br />

(Lijinsky et al., 1980). This was confirmed in 2000 (Cunningham, 2000).<br />

Fatalities occurred on over dosage (Winek et al., 1977). It was banned<br />

because it could cause liver tumours in rats if given 25 to 30 times the normal<br />

human dose throughout the animal’s normal lifespan (Lewis, 1979).<br />

SED 1952: one fatal case in a 16 month child: anuria, cerebral oedema,<br />

nephrosis and toxic psychosis (Rives et al., 1949).

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!